Amyloidosis trials in Denmark
4 of 16 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Where
- Aarhus, Copenhagen
- People
- 1,500 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT04561518 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462 - No phaseTaking peopleOverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- Where
- Horsens
- People
- 52,121 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06355934 - No phaseTaking peoplePhenotyping and Characterization of wtATTR-CM (TRACE 1)
- Where
- Aarhus
- Age
- 18 years and over
- People
- 120
- Run by
- Steen Hvitfeldt Poulsen
See details and how to joinNCT06291805